IMMUTEP Ltd
Pharmaceutical company · Sydney,, New South Wales, Australia · Nasdaq: IMMP
IMMUTEP Ltd is a pharmaceutical company headquartered in Sydney,, New South Wales, Australia. Its shares trade on Nasdaq under the ticker IMMP. It has reported private securities offerings to the US SEC, most recently $520,674 sold in a notice filed in 2019.
IMMUTEP at a glance
What does IMMUTEP do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $520,674 sold (2019).
Frequently asked questions about IMMUTEP
Where is IMMUTEP headquartered?
IMMUTEP Ltd is headquartered in Sydney,, New South Wales, Australia.
What does IMMUTEP do?
IMMUTEP Ltd is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is IMMUTEP a public company?
Yes. IMMUTEP Ltd trades on Nasdaq under the ticker IMMP.
Similar companies
- Kazia Therapeutics LtdSydney, New South Wales, Australia
- Propanc Biopharma, Inc.Camberwell, Victoria, Australia
- Radiopharm Theranostics LtdCarlton, Victoria, Australia
- Alterity Therapeutics LtdMelbourne, Victoria, Australia
- Immuron LtdCarlton, Victoria, Australia
- Cyclomedica Australia PTY LtdKingsgrove, New South Wales, Australia
- Botanix Pharmaceuticals Ltd.North Perth, Western Australia, Australia
- Telix Pharmaceuticals LtdNorth Melbourne, Victoria, Australia
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences